hydroxychloroquine has been researched along with Peritonitis in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of old-onset lupus peritonitis treated successfully by Hydroxychloroquine." | 7.80 | Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus. ( Bdioui, F; Hammami, S; Loghmari, H; Mahjoub, S; Ouaz, A; Saffar, H, 2014) |
| " We report a case of old-onset lupus peritonitis treated successfully by Hydroxychloroquine." | 3.80 | Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus. ( Bdioui, F; Hammami, S; Loghmari, H; Mahjoub, S; Ouaz, A; Saffar, H, 2014) |
| "After two months, a systemic lupus erythematosus was diagnosed." | 1.62 | Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus. ( Carvalho, JF; Shoenfeld, Y; Silva, FF, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, JF | 1 |
| Silva, FF | 1 |
| Shoenfeld, Y | 1 |
| Hammami, S | 1 |
| Bdioui, F | 1 |
| Ouaz, A | 1 |
| Loghmari, H | 1 |
| Mahjoub, S | 1 |
| Saffar, H | 1 |
| Durieux, S | 1 |
| Rozenberg, S | 1 |
| Bourgeois, P | 1 |
3 other studies available for hydroxychloroquine and Peritonitis
| Article | Year |
|---|---|
Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Antinuclear; Antiphospholipid Syndrome; Catastrophic Illness; Female; Hepari | 2021 |
Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus.
Topics: Age of Onset; Aged; Ascites; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Peri | 2014 |
[Complications of colonic diverticular disease during rheumatoid polyarthritis: 7 cases].
Topics: Abscess; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; | 1999 |